Treating Immuno-metabolic Depression With Anti-inflammatory Drugs

NCT05415397 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Depressive Disorder, Major
Inflammation

Interventions

DRUG: Celecoxib 400mg
DRUG: Placebo

Sponsor

Amsterdam UMC, location VUmc

Collaborators

[object Object]